Cargando…
New-onset refractory status epilepticus due to autoimmune encephalitis after vaccination against SARS-CoV-2: First case report
BACKGROUND: Vaccination against SARS-CoV-2 has been conducted frequently to limit the pandemic but may rarely be associated with postvaccinal autoimmune reactions or disorders. CASE PRESENTATION: We present a 35-year-old woman who developed fever, skin rash, and headache 2 days after the second SARS...
Autores principales: | Werner, Jana, Brandi, Giovanna, Jelcic, Ilijas, Galovic, Marian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424760/ https://www.ncbi.nlm.nih.gov/pubmed/36051224 http://dx.doi.org/10.3389/fneur.2022.946644 |
Ejemplares similares
-
Multimodal Predictions of Super-Refractory Status Epilepticus and Outcome in Status Epilepticus Due to Acute Encephalitis
por: Yuan, Fang, et al.
Publicado: (2018) -
Neuromodulation in new-onset refractory status epilepticus
por: Stavropoulos, Ioannis, et al.
Publicado: (2023) -
Perspective: Vagal nerve stimulation in the treatment of new-onset refractory status epilepticus
por: Mantoan Ritter, Laura, et al.
Publicado: (2023) -
Editorial: Advances in diagnosing and treating new-onset refractory status epilepticus (NORSE)
por: Thomschewski, Aljoscha, et al.
Publicado: (2023) -
Seizure burden and neuropsychological outcomes of new-onset refractory status epilepticus: Systematic review
por: Taraschenko, Olga, et al.
Publicado: (2023)